化合物KB-0742 dihydrochloride T9446

Product Introduction
Bioactivity


英文名: KB-0742 dihydrochloride

描述: KB-0742 dihydrochloride 是一种有效的、选择性的、口服的 CDK9 抑制剂，具有抗肿瘤活性，对CDK9/cyclin T1的IC50为 6 nM。它对CDK9/cyclin T1具有选择性，其选择性是其他 CDK 激酶的 50 倍以上。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 60 mg/mL (166.51 mM)


关键字: KB 0742 | inhibit | CDK | CDK9 | KB-0742 | KB-0742 Dihydrochloride | Ser7 | Ser2 | KB0742 | CRPC | KB 0742 dihydrochloride | antiproliferative | Cyclin dependent kinase | KB 0742 Dihydrochloride | Ser5 | KB0742 Dihydrochloride | oral | Inhibitor | KB0742 dihydrochloride | anticancer

相关产品: WAY-322243 | Palbociclib monohydrochloride | Men 10376 | PHA-767491 | CDK9-IN-8 | Amsilarotene | HS-243 | CDK12-IN-3 | CDK4-IN-1 | Palbociclib orotate

相关库: Drug Repurposing Compound Library | Anti-Breast Cancer Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Clinical Compound Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Kinase Inhibitor Library | Anti-Cancer Active Compound Library | Bioactive Compound Library

化合物KB-0742 dihydrochloride T9446信息由TargetMol中国为您提供，如您想了解更多关于化合物KB-0742 dihydrochloride T9446报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途